fb

Allergy-Based Eczema Treatment in NYC

Achieve Long-term Relief from Eczema by Addressing the Root Cause

Eczema (atopic dermatitis) is a chronic condition marked by persistent skin inflammation. It can manifest as itching, irritated skin, often in patches. Part of the difficulty patients face with eczema is how it can worsen (flare up) and recede, often without the patient knowing why. While eczema flare-ups can be triggered by a range of causes, such as weather and stress, allergies play a central role. By addressing this root cause, Dr. Shukla’s allergy-based eczema treatment in NYC can help patients achieve long-term control over this chronic condition.
Ready to Schedule an Appointment with Dr. Shukla?

Why Target Allergies for Controlling Eczema?

In many patients, eczema is not simply a skin problem. Rather, it is intrinsically tied to the body’s allergic immune response. Many other approaches simply try to help patients manage eczema symptoms. While this may provide temporary improvements, it does not proactively focus on the root cause.

Dr. Shukla’s clinically backed approach uses elements such as immunotherapy and biologics to prevent flare-ups in the first place, rather than the reactive approach to symptom suppression.

How Do Allergies Lead to Eczema?

Atopic dermatitis is an immune-mediated, allergy-driven condition. Studies show consistent links between contact with allergens and eczema exacerbations. That means you could see flare-ups when exposed to:
  • Environmental allergens (pollen, dust mites, pet dander)
  • Food sensitivities (in select patients)
  • Contact allergens (fragrances, metals, skincare ingredients)

The allergic response involves the immune system overreacting to harmless substances. Most people associate allergies with upper respiratory symptoms, like sneezing, a runny nose, or even difficulty breathing. However, allergies can also trigger inflammation in the skin barrier, leading to the characteristic redness, itching, and scaling of eczema.

In short, a significant percentage of chronic eczema cases are rooted in untreated allergies.

Acute Cases of Contact Dermatitis

Eczema can also be caused when certain materials come into contact with the skin. In such cases, called contact dermatitis, the cause can be due to an irritant or contact with allergens. In such cases, treating underlying allergies can still lead to notable improvement, reducing the skin’s reaction to targeted allergens.

How to Start: Comprehensive Allergy Testing for Eczema

Eczema treatment with Dr. Shukla begins with an allergy assessment, using methods such as:
  • Skin prick testing
  • Blood testing (specific IgE)
  • Patch testing (contact allergens)

These tests can identify root triggers, especially for less obvious allergies like indoor allergens.

Treatment Options for Allergy-Based Eczema

Allergy Desensitization (Immunotherapy)

Immunotherapy works through gradually exposing the immune system to allergens to retrain it. Over time, this leads to a decreased reaction to the targeted allergens. With the immune system retrained, patients can see long-term improvements rather than temporary symptom relief.

Dr. Shukla offers two main approaches to immunotherapy: shots and drops/tablets.

Allergy Shots: Subcutaneous Immunotherapy (SCIT)

SCIT involves receiving injections under the skin in Dr. Shukla’s medical office. After each shot, Dr. Shukla monitors you for about 30 minutes to ensure your safety. The first phase (build-up phase) involves receiving shots 1–2 times a week for about 3–6 months. Following that is the maintenance phase, with shots every 2–4 weeks for 3–5 years. By completion of the regimen, patients should build up relief from the targeted allergic reactions.

  • Best for: Moderate to severe environmental allergies (pollen, dust mites, pet dander). Ideal for patients with atopic dermatitis triggered by environmental allergens.
  • Results: Can reduce eczema severity by ~50% in allergy-driven cases.

Drops/Tablets: Sublingual Immunotherapy (SLIT)

SLIT involves receiving drops or tablets that you place under your tongue. You will receive the first dose in-office with Dr. Shukla’s supervision. From there, you can take the remaining doses as scheduled at home. A full regimen consists of daily dosing over a span of several months to years. Since there are no injections, it can prove convenient for needle-averse patients or children.

  • Best for: Select allergens (commonly pollen, dust mites)
  • Results: Can reduce eczema severity by ~50% in allergy-driven cases (for select allergens).

Biologic Therapies for Moderate to Severe Eczema

Dr. Shukla also offers biologics to treat eczema. This advanced therapy blocks specific inflammatory pathways by targeting specific immune signalers. This modern approach to allergy treatment can result in a significant reduction in itching and inflammation, proving useful when traditional treatments are insufficient.

  • Best for: Severe, persistent, or widespread eczema
  • Results: Up to 75% improvement in symptoms.

Topical Treatments

While they do not address the underlying cause, topical treatments are excellent for control of flare-ups. These can include:

  • PDE4 Inhibitors: Ointments or creams that can be used regularly to improve flare-up symptoms. Roflumilast (Zoryve) in particular is approved for mild to moderate atopic dermatitis in patients 6 years and older.
  • Aryl Hydrocarbon Receptor Agonist: A daily cream that can help reduce inflammation.
  • Topical JAK Inhibitors: The active ingredient in ruxolitinib (Opzelura) has been approved for children as young as 2 years old. Delgocitinib (Anzupgo), is approved for moderate-to-severe hand eczema in adults who have not had success with topical corticosteroids.
  • Calcineurin Inhibitors: These topicals are ideal for more sensitive areas like the face and eyelids and avoid the risk of skin thinning associated with steroids.
  • Topical Corticosteroids: Best for targeting acute flares but only suitable for short-term use.

Photochemotherapy

This noninvasive treatment involves the application of tar or petrolatum followed by ultraviolet B light therapy. Also known as the Goeckerman treatment, it has shown efficacy for extensive or severe skin conditions, often proving useful if topical treatments did not show improvements.

Combining Treatments for Optimal Results

Seeing optimal treatment outcomes often involves a multilayered approach. It always starts with trigger identification and avoidance. From there, patients may have a combination of immunotherapy and topical treatments to achieve excellent eczema control. Symptom management can still play a part, but targeting the root cause is the only pathway to seeing long-term results with broader benefits.

Benefits of Treating the Root Cause

  • Fewer flare-ups
  • Reduced reliance on steroids
  • Improved skin barrier function
  • Better quality of life
  • Long-term symptom control

Eczema Treatment FAQs

Steroids can certainly provide symptom relief and control eczema. However, they are not a long-term solution. Studies show that adverse effects increase with long-term steroid use, including an increased risk of:

  • Significant bone density loss (osteoporosis) and increased fracture risk
  • Metabolic changes such as high blood sugar (steroid-induced diabetes), fluid retention, and weight gain
  • Immune system suppression, increasing vulnerability to infections
  • Cardiovascular, ophthalmologic, and dermatological issues
  • Muscle weakness
  • Potential psychological/neurological issues like mood lability, anxiety, and insomnia

Some key characteristics of good candidates, both children and adults alike, include:

  • Having chronic or recurring eczema
  • Having seasonal flare-ups
  • Having known allergies (asthma, hay fever, etc.)
  • Noting a poor response to topical treatments alone
  • Wanting to avoid long-term adverse effects of other treatment options

Many cases of eczema arise from an allergic immune response combined with a weakened skin barrier.

Currently, there is no cure for eczema in the traditional sense. Rather, treatments focus on effective, lasting control by influencing the body’s immune response to triggers.

Yes, many patients experience seasonal flare-ups directly related to allergens, such as during pollen seasons or winter months.

Dr. Shukla’s allergy-focused approach goes beyond reactive symptom control. Rather, he uses a proactive combination of testing and immune-based treatments to help patients see relief that lasts years rather than days. His decades of experience in allergy treatment are suitable for addressing even complex or severe cases of eczema.

Begin Controlling Eczema Today

Lasting eczema relief starts with a personal consultation with Dr. Mayank Shukla. Call our office at (917) 924-6383 or use our online form to schedule your consultation and assessment with NYC’s leading provider of allergy-based eczema treatment today.

Awards and Recognition

Dr. Mayank Shukla Top-Rated Pulmonologist 2018 - 2026

Contact His New York Asthma Treatment Clinic Today!

Find Us On Map
Find a clinic near you
Call for an appointment!
Call for an appointment!
Send an Email
Feel free to message Us!